ADAURA: Overall Survival Analysis of Osimertinib in NSCLC
July 7th 2023Charu Aggarwal, MD, MPH, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss recent data updates from the ADAURA trial, an overall survival analysis of osimertinib in non–small cell lung cancer (NSCLC).
Watch
Biomarker Analysis Shows Better Outcomes for Undetectable ctDNA in GIST
July 6th 2023Jonathan C. Trent, MD, PhD, discusses the molecular analyses of the INTRIGUE study, which was supported by Caris Life Science’s Precision Oncology Alliance, investigating patients with GIST that were presented at ASCO 2023.
Watch
Key Takeaways: The Evolving Treatment Landscape of Breast Cancer Management
July 6th 2023Following their interview with Stephanie Graff, MD, FACP, the Oncology Brothers share key takeaways from the NATALEE, SONIA, and X-7/7 trials and consider how they will impact the management of breast cancer.
Watch
Determining the Role of Combination CDK4/6i + AI Therapy in HR+ mBC: The SONIA Trial
July 6th 2023Shared insight from the Oncology Brothers and Stephanie Graff, MD, FACP, on the role of CDK4/6 inhibition in combination with aromatase inhibitor therapy following data from the SONIA trial in HR+ metastatic breast cancer.
Watch